Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose ticagrelor versus clopidogrel for coronary flow reserve after elective PCI in diabetes
2019-002226-79Phase 4Terminated
- Sponsor
- Region Skåne
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in coronary arteriosclerosis comparing Low maintenance dose ticagrelor with Standard-dose clopidogrel (2 arms). Started Sep 2019; status: terminated.
02
Drugs
ticagrelorclopidogrel
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2019-002226-79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002226-79.